Stocks
Anika Therapeutics (ANIK) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -4.16 | 18.2 | 15.1 | 3.02 | -3.58 | -6.63 | ||
| Changes by years, y/y, % | +315% | -536% | -17% | -80% | -218% | +28.9% | |||
Anika Therapeutics. EBITDA US GAAP, bln rub
Anika Therapeutics. EBITDA US GAAP, changes, %
Anika Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Anika Therapeutics (ANIK) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -2.69 | -2.47 | -0.836 | 2.08 | -3.41 | -6.63 | |
| Changes by years, y/y, % | +44% | -1 094% | -97% | -92% | +27% | |||
| Changes by quarters, q/q, % | -110% | -8% | -66% | -349% | -264% | |||
